Global Chemoinformatics Market
Chemicals

Insights Into The Chemoinformatics Market’s Growth Potential 2024-2033

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

 

The chemoinformatics market has exhibited steady growth, progressing from $4.28 billion in 2023 to a projected $4.4 billion in 2024, indicating a Compound Annual Growth Rate (CAGR) of 2.8%. The historic growth can be attributed to factors such as high throughput screening (HTS), data availability, drug discovery efficiency, personalized medicine, and the integration of artificial intelligence (AI) and machine learning.

  • Key Driver: Chronic Disease Prevalence: The increasing prevalence of chronic diseases stands out as a significant driver for the chemoinformatics market. Chronic diseases, lasting a year or longer, necessitate ongoing medical attention. Chemoinformatics plays a crucial role in drug discovery and the exploration of novel chemicals for treating diseases like neglected tropical diseases.
  • Global Health Impact: According to the World Health Organization, an estimated 500 million people are expected to develop chronic diseases, including obesity, diabetes, and heart diseases, between 2020 and 2030. Immediate global actions are required to address physical inactivity, emphasizing the critical role of chemoinformatics in advancing healthcare solutions.
  • Market Players: Leading companies contributing to the chemoinformatics market include ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, and OpenEye Scientific Software Inc., among others. These entities play a pivotal role in advancing technologies and supporting the demand for chemoinformatics.

 

Technological Advances In The Chemoinformatic Market
Technological advances emerge as a prominent trend in the chemoinformatics market, with key players developing sophisticated software and platforms to maintain their market positions. Notably, Optibrium, a UK-based developer, launched StarDrop 7.0, showcasing the integration of artificial intelligence (AI) technology, enhanced workflows, and seamless collaboration with Optibrium’s Cerella platform.

  • Optibrium’s StarDrop 7.0: Released in January 2021, StarDrop 7.0 facilitates drug discovery scientists with unique AI capabilities, improved compound design techniques, and seamless integration with Cerella. The software aims to expedite discovery cycles, reduce expenses, and focus on delivering high-quality compounds.
  • Strategic Acquisition: Cadence Design Systems, a US-based software company, acquired OpenEye Scientific Software in September 2022. This acquisition aligns with Cadence’s Intelligent System Design strategy, extending its expertise into molecular modeling and simulation for life sciences.

 

Market Segmentation: Understanding Diverse Applications
The chemoinformatics market is segmented based on type, application, and end-user, providing a comprehensive view of its applications in various domains.

  1. Type Segmentation: Chemistry, Computer Science, Information Science.
  2. Application Segmentation: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications.
  3. End-User Segmentation: Chemical and Pharmaceutical Industries, Research and Academic Institutions, Other End Users.
  • Regional Dynamics: North America took the lead in the chemoinformatics market in 2023, with Asia-Pacific anticipated as the fastest-growing region in the forecast period.

In conclusion, the chemoinformatics market’s growth is intricately linked to addressing the surging prevalence of chronic diseases, with technological advances and strategic acquisitions driving innovation in the field. The market’s segmentation reflects its diverse applications, playing a crucial role in shaping the future of drug discovery and healthcare solutions.

 

Get A Free Sample On The Global Chemoinformatics Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=7806&type=smp

 

Read The Full Chemoinformatics Market Report Here:
https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report

 

The Chemoinformatics Global Market Report 2024  provides an overview of the chemoinformatics market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The chemoinformatics market forecast analyzes chemoinformatics market size, chemoinformatics market share, leading competitor and their market positions.

 

The Table Of Content For The Chemoinformatics Market Include:
1. Chemoinformatics Market Executive Summary
2. Chemoinformatics Market Segments
3. Chemoinformatics Market Size And Chemoinformatics Market Growth Rate
4. Key Chemoinformatics Market Trends
5. Major Chemoinformatics Market Drivers
……
25. Key Mergers And Acquisitions In The Chemoinformatics Market
26. Top Chemoinformatics Companies
27. Chemoinformatics Market Opportunities And Strategies
28. Chemoinformatics Market, Conclusions And Recommendations
29. Appendix

 

Explore Similar Reports From The Business Research Company:
Bioinformatics Global Market Report 2024
Laboratory Informatics Global Market Report 2024
Intravenous Infusion Pumps Global Market Report 2024

 

Learn More About The Business Research Company
The Business Research Company has published over 6500+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

 

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *